Mutual Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.66M | Buy |
3,307
+57
| +2% | +$27.4K | 0.03% | 468 |
|
|
2026
Q1 | $1.6M | Buy |
3,250
+499
| +18% | +$271K | 0.03% | 444 |
|
|
2025
Q4 | $1.59M | Sell |
2,751
-64
| -2% | -$36.2K | 0.03% | 419 |
|
|
2025
Q3 | $1.61M | Sell |
2,815
-451
| -14% | -$210K | 0.04% | 423 |
|
|
2025
Q2 | $1.56M | Buy |
3,266
+853
| +35% | +$357K | 0.04% | 373 |
|
|
2025
Q1 | $1.02M | Sell |
2,413
-78
| -3% | -$42.2K | 0.03% | 439 |
|
|
2024
Q4 | $1.4M | Sell |
2,491
-112
| -4% | -$61.6K | 0.04% | 374 |
|
|
2024
Q3 | $1.45M | Buy |
2,603
+256
| +11% | +$152K | 0.04% | 358 |
|
|
2024
Q2 | $1.42M | Buy |
2,347
+363
| +18% | +$208K | 0.04% | 360 |
|
|
2024
Q1 | $1.15M | Sell |
1,984
-227
| -10% | -$127K | 0.04% | 436 |
|
|
2023
Q4 | $1.17M | Buy |
2,211
+188
| +9% | +$91K | 0.04% | 409 |
|
|
2023
Q3 | $1.02M | Buy |
2,023
+122
| +6% | +$65K | 0.04% | 418 |
|
|
2023
Q2 | $992K | Buy |
1,901
+125
| +7% | +$67.5K | 0.04% | 437 |
|
|
2023
Q1 | $1.02M | Buy |
1,776
+76
| +4% | +$42.8K | 0.04% | 418 |
|
|
2022
Q4 | $936K | Buy |
1,700
+43
| +3% | +$22.8K | 0.04% | 425 |
|
|
2022
Q3 | $840K | Buy |
1,657
+197
| +13% | +$110K | 0.04% | 415 |
|
|
2022
Q2 | $793K | Buy |
1,460
+19
| +1% | +$10.5K | 0.05% | 400 |
|
|
2022
Q1 | $851K | Buy |
1,441
+39
| +3% | +$22.4K | 0.05% | 422 |
|
|
2021
Q4 | $936K | Buy |
1,402
+90
| +7% | +$56.2K | 0.05% | 404 |
|
|
2021
Q3 | $750K | Sell |
1,312
-113
| -8% | -$62K | 0.04% | 426 |
|
|
2021
Q2 | $719K | Sell |
1,425
-12
| -0.8% | -$5.66K | 0.04% | 439 |
|
|
2021
Q1 | $656K | Sell |
1,437
-111
| -7% | -$53K | 0.04% | 425 |
|
|
2020
Q4 | $721K | Buy |
1,548
+43
| +3% | +$20.2K | 0.05% | 390 |
|
|
2020
Q3 | $665K | Buy |
1,505
+44
| +3% | +$18.2K | 0.06% | 351 |
|
|
2020
Q2 | $529K | Buy |
1,461
+100
| +7% | +$33.5K | 0.05% | 366 |
|
|
2020
Q1 | $386K | Buy |
1,361
+126
| +10% | +$39.7K | 0.05% | 339 |
|
|
2019
Q4 | $401K | Sell |
1,235
-131
| -10% | -$39.7K | 0.04% | 398 |
|
|
2019
Q3 | $398K | Sell |
1,366
-51
| -4% | -$14.6K | 0.05% | 357 |
|
|
2019
Q2 | $416K | Buy |
1,417
+472
| +50% | +$130K | 0.05% | 360 |
|
|
2019
Q1 | $259K | Buy |
+945
| New | +$235K | 0.04% | 392 |
|
Other funds holding TMO
Mutual Advisors's TMO Position: Q2 2026 in Review
Mutual Advisors increased its Thermo Fisher Scientific (TMO) stake by 1.8% in Q2 2026, buying an estimated $27.4K and bringing the position to 3,307 shares worth $1.66M. The position accounts for 0.03% of the portfolio, ranked #468.
Mutual Advisors first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Mutual Advisors held 3,307 shares of Thermo Fisher Scientific worth $1.66M as of Q2 2026.
- Mutual Advisors bought 57 Thermo Fisher Scientific shares in Q2 2026, an estimated $27.4K.
- Thermo Fisher Scientific made up 0.03% of Mutual Advisors's portfolio in Q2 2026, its #468 holding.
- Mutual Advisors first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.